Stocks fluctuate as traders assess AI fallout, tariffs

Weather - Sydney 10°C

Stocks fluctuate as traders assess AI fallout, tariffs

ECONOMY 24.02.2026

Stocks fluctuate as traders assess AI fallout, tariffs / Photo: © AFP

Stock markets fluctuated on Tuesday as US President Donald Trump's new tariffs on imports came into effect, with investors also weighing renewed AI concerns.

Change text size:

Markets have largely taken in stride the US Supreme Court's decision to strike down much of Trump's tariff policy and his subsequent move to impose tariffs, initially set at 10 percent, under a different legal authority.

Trump has vowed to raise this level to 15 percent, with exclusions expected to remain for goods covered by sector-specific arrangements and the US-Mexico-Canada trade pact.

However, the move has raised questions about other trade deals Washington has agreed since Trump's tariff blitz in April, with the European Union demanding clarity on the issue before ratifying its agreement.

Major European indices were little changed near midday Tuesday, with London and Frankfurt dipping and Paris edging higher.

"Investors are wary as they brace for further volatility sparked by unpredictable US trade policy and the fallout from AI advances," said Susannah Streeter, chief investment strategist at Wealth Club.

Observers said 2026 could see more tariff-based friction but they did not expect it to be as painful for markets as last year's upheaval.

Sentiment was also dampened by renewed concerns about the impact of artificial intelligence on the tech sector, with software firms again in the firing line.

The latest blow came from a report Sunday by a firm called Citrini Research that used possible scenarios set in the future showing parts of the global economy that could be at risk from new tools, such as credit card and food delivery firms.

Adding to the downbeat mood was a post by Anthropic saying its Claude chatbot could help to update the COBOL programming language used on IBM computers. IBM fell more than 13 percent in New York.

"Traders are concerned with the degree to which AI will disrupt rather than enhance corporate profitability and overall levels of employment," said Joshua Mahony, chief market analyst at Scope Markets.

The releases come after Anthropic earlier this month unveiled a model that could replace numerous software tools, including for legal work and data marketing.

While all three main indexes on Wall Street closed down at least one percent, Asia markets fared slightly better on Tuesday.

Shanghai returned from a week-long holiday to rally, while Tokyo also rose and Hong Kong retreated.

The yen fell against the dollar following local media reports that Japanese Prime Minister Sanae Takaichi had voiced concerns about additional interest rate hikes with Bank of Japan governor, Kazuo Ueda.

- Key figures at around 1100 GMT -

London - FTSE 100: DOWN 0.2 percent at 10,666.12 points

Paris - CAC 40: UP 0.1 percent at 8,507.13

Frankfurt - DAX: DOWN 0.1 percent at 24,975.15

Tokyo - Nikkei 225: UP 0.9 percent at 57,321.09 (close)

Hong Kong - Hang Seng Index: DOWN 1.8 percent at 26,590.32 (close)

Shanghai - Composite: UP 0.9 percent at 4,117.41 (close)

New York - Dow: DOWN 1.7 percent at 48,804.06 (close)

Euro/dollar: DOWN at $1.1780 from $1.1792 on Monday

Pound/dollar: DOWN at $1.3487 from $1.3492

Euro/pound: DOWN at 87.38 pence from 87.40 pence

Dollar/yen: UP at 155.89 yen from 154.68 yen

Brent North Sea Crude: DOWN 0.2 percent at $70.98 per barrel

West Texas Intermediate: DOWN 0.1 percent at $66.25 per barrel

V.Bennett--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - Stocks fluctuate as traders assess AI fallout, tariffs